Strikingly, both TAM depletion and macrophage‐specific VEGF deletion accelerated tumor growth significantly, and conversely, treatment with recombinant CSF‐1 delayed glioma growth while accelerating the vessel dysmorphia. Here, CSF1 is linked to central nervous system cancer.